Erik J Forsberg
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.2MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 16, 2016 | NIH | SBIR Phase I Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications | $217K | Regenerative Medical Solutions Inc |
| Sep 16, 2016 | NIH | SBIR Phase I Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell function | $225K | Regenerative Medical Solutions Inc |
| Sep 1, 2016 | NIH | SBIR Phase II Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing | $801K | Regenerative Medical Solutions Inc |
| Jul 20, 2016 | NIH | SBIR Phase I Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells | $225K | Regenerative Medical Solutions Inc |
| Sep 16, 2015 | NIH | SBIR Phase II Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing | $699K | Regenerative Medical Solutions Inc |
Peer ranks
Federal funding#916
Awards as PI#417
Patents#273
Companies
- Regenerative Medical Solutions IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.